ALFACELL CORP
8-K, 1999-07-13
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: MAMMATECH CORP, 10-Q, 1999-07-13
Next: CENTOCOR INC, SC 13G/A, 1999-07-13





                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT


     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

          Date of Report (Date of earliest event reported) July 9, 1999

                              ALFACELL CORPORATION

             (Exact name of registrant as specified in its charter)


Delaware                             0-11088                        22-2369085
(State or other jurisdiction       (Commission                    (IRS Employer
of incorporation)                  File Number)                  Identification)


             225 Belleville Avenue Bloomfield, New Jersey 07003
             (Address of principal executive offices)  (Zip Code)


        Registrant's telephone number, including area code (973) 748-8082



                  --------------------------------------------
          (Former name or former address, if changed since last report)


<PAGE>


Item 5. Other Events.

     On July 9, 1999, the Company  announced  that Gail E. Fraser  resigned as a
director and Chief Financial Officer of Alfacell Corporation (the "Registrant").
Strategic  and daily  business  operations  will  remain the  responsibility  of
Kuslima Shogen,  Alfacell's Chairman and Chief Executive Officer. KPMG LLP (Peat
Marwick) will continue in its capacity as external  auditors for the  Registrant
and will  interact  directly  with Ms.  Shogen  and the Audit  Committee  of the
Registrant's Board of Directors. The Sage Group will continue to handle business
development activities for the Registrant.


<PAGE>


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized. Dated: July 12, 1999


                                                   ALFACELL CORPORATION
                                                   ---------------------------
                                                   (Registrant)

                                              By:  /s/ Kuslima Shogen
                                                   ---------------------------
                                                   KUSLIMA SHOGEN
                                                   Chief Executive Officer





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission